Unapproved drops for dry eyes pose risks: Govt
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward
Govt highlights multi-layer framework to curb misleading advertisements
Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal
Study finds rising resistance to a last-resort antibiotic in Africa
Patna: Over 20,000 Banned Injections Seized in Ramkrishna Nagar Area, One Arrested
Pharma Company Bus Overturns in Miyapur, 10 Employees Injured, Probe Underway
India regulator asks states to implement uniform drug licensing norms to end quality gaps
Sale of fake obesity drugs driven by high prices, weight-loss desire prompts health concernLupin gets USFDA nod for myelodysplastic syndrome drug
New Delhi: Drug firm Lupin Thursday said it has received approval from the US health regulator to market Decitabine for injection, used for the treatment of myelodysplastic syndromes (MDS). The…
Centre, AAP govt not ensuring regular supply of drugs to treat HIV: plea in HC
New Delhi: The Delhi High Court has sought the Centre’s stand on a plea alleging that it and the AAP government were not following through on their assurance to the…
Aurobindo Pharma to launch oncology, respiratory products in US by 2021
NEW DELHI: Aurobindo Pharma is looking to launch first set of oncology, respiratory, complex injectables and topical products in the US in the next three years as part of plans…
E-pharmacies divided over their legal status
India’s online pharmacy startups are a divided house. Two factions in the nascent e-pharmacy segment have taken diametrically opposite view on a public interest litigation that challenges the legality of…
E-pharmacies divided over their legal status
India’s online pharmacy startups are a divided house. Two factions in the nascent e-pharmacy segment have taken diametrically opposite view on a public interest litigation that challenges the legality of…
Pharma shares bullish; Cipla rises around 3%
NEW DELHI: Pharma shares were trading higher with the Nifty Pharma index up 0.75 per cent at 9287.5 on Friday. Shares of Cipla (up 2.62 per cent), Divi’s Laboratories (up…
HC poser on resale of expired meds
New Delhi: Delhi high court on Friday sought the Centre’s stand on a PIL that claimed rampant sale of expired drugs by chemists who erase the original manufacturing and expiry…
Stem Cell Scientists’ upcoming Kumbh in Delhi is billed as a turning point
New Delhi: Therapeutic potential of stem cells is making headlines in India like never before. Its efficacy in treating a wide range of diseases is being duly testified by success…
Medanta sets a bench mark in bypass surgery
Gurugram/ Delhi: It seems Dr Naresh Trehan, globally renowned heart surgeon, is in ownership of all hearts under the sun. Where other heart surgeons fear to tread, he straddles with…
Eli Lilly considers sale of off-patent drug assets in China
Eli Lilly and Co is considering the sale of an off-patent drugs portfolio in China, Bloomberg reported on Friday, citing sources. The assets, which include antibiotics and treatments for central…